U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07813663) titled 'A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP269 in Healthy Male and Female Participants' on Sept. 04.

Brief Summary: This study will characterize the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) of JZP269 in healthy participants.

Study Start Date: Sept. 22

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: JZP269

Administered as described.

DRUG: Placebo

Administered as described.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jazz Pharmaceuticals

Disclaimer: Curated by HT Syndication....